Literature DB >> 32971013

Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.

Anne Cathrine Staff1, Heidi E Fjeldstad2, Ingrid Knutsdotter Fosheim2, Kjartan Moe3, Gitta Turowski4, Guro Mørk Johnsen5, Patji Alnaes-Katjavivi5, Meryam Sugulle2.   

Abstract

Physiological transformation with remodeling of the uteroplacental spiral arteries is key to a successful placentation and normal placental function. It is an intricate process that involves, but is not restricted to, complex interactions between maternal decidual immune cells and invasive trophoblasts in the uterine wall. In normal pregnancy, the smooth muscle cells of the arterial tunica media of uteroplacental spiral arteries are replaced by invading trophoblasts and fibrinoid, and the arterial diameter increases 5- to 10-fold. Poor remodeling of the uteroplacental spiral arteries is linked to early-onset preeclampsia and several other major obstetrical syndromes, including fetal growth restriction, placental abruption, and spontaneous preterm premature rupture of membranes. Extravillous endoglandular and endovenous trophoblast invasions have recently been put forth as potential contributors to these syndromes as well. The well-acknowledged disturbed extravillous invasion of maternal spiral arteries in preeclampsia is summarized, as are briefly novel concepts of disturbed extravillous endoglandular and endovenous trophoblast invasions. Acute atherosis is a foam cell lesion of the uteroplacental spiral arteries associated with poor remodeling. It shares some morphologic features with early stages of atherosclerosis, but several molecular differences between these lesions have also recently been revealed. Acute atherosis is most prevalent at the maternal-fetal interface, at the tip of the spiral arteries. The localization of acute atherosis downstream of poorly remodeled arteries suggests that alterations in blood flow may trigger inflammation and foam cell development. Acute atherosis within the decidua basalis is not, however, confined to unremodeled areas of spiral arteries or to hypertensive disorders of pregnancy and may even be present in some clinically uneventful pregnancies. Given that foam cells of atherosclerotic lesions are known to arise from smooth muscle cells or macrophages activated by multiple types of inflammatory stimulation, we have proposed that multiple forms of decidual vascular inflammation may cause acute atherosis, with or without poor remodeling and/or preeclampsia. Furthermore, we propose that acute atherosis may develop at different gestational ages, depending on the type and degree of the inflammatory insult. This review summarizes the current knowledge of spiral artery remodeling defects and acute atherosis in preeclampsia. Some controversies will be presented, including endovascular and interstitial trophoblast invasion depths, the concept of 2-stage trophoblast invasion, and whether the replacement of maternal spiral artery endothelium by fetal endovascular trophoblasts is permanent. We will discuss the role of acute atherosis in the pathophysiology of preeclampsia and short- and long-term health correlates. Finally, we suggest future opportunities for research on this intriguing uteroplacental interface between the mother and fetus.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  decidua; hypertension; immunology; pathophysiology; placenta; preeclampsia; pregnancy; spiral artery

Mesh:

Year:  2020        PMID: 32971013     DOI: 10.1016/j.ajog.2020.09.026

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  37 in total

Review 1.  Exposure to toxic metals and per- and polyfluoroalkyl substances and the risk of preeclampsia and preterm birth in the United States: a review.

Authors:  Juliana Stone; Pragna Sutrave; Emily Gascoigne; Matthew B Givens; Rebecca C Fry; Tracy A Manuck
Journal:  Am J Obstet Gynecol MFM       Date:  2021-01-11

Review 2.  The etiology of preeclampsia.

Authors:  Eunjung Jung; Roberto Romero; Lami Yeo; Nardhy Gomez-Lopez; Piya Chaemsaithong; Adithep Jaovisidha; Francesca Gotsch; Offer Erez
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

3.  Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.

Authors:  Roberto Romero; Eunjung Jung; Tinnakorn Chaiworapongsa; Offer Erez; Dereje W Gudicha; Yeon Mee Kim; Jung-Sun Kim; Bomi Kim; Juan Pedro Kusanovic; Francesca Gotsch; Andreea B Taran; Bo Hyun Yoon; Sonia S Hassan; Chaur-Dong Hsu; Piya Chaemsaithong; Nardhy Gomez-Lopez; Lami Yeo; Chong Jai Kim; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2022-09-03       Impact factor: 10.693

Review 4.  Single-Cell Immunobiology of the Maternal-Fetal Interface.

Authors:  Derek Miller; Valeria Garcia-Flores; Roberto Romero; Jose Galaz; Roger Pique-Regi; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2022-10-15       Impact factor: 5.426

Review 5.  Hypertensive disorders and maternal hemodynamic changes in pregnancy: monitoring by USCOM® device.

Authors:  Elisa Montaguti; Gaetana Di Donna; Aly Youssef; Gianluigi Pilu
Journal:  J Med Ultrason (2001)       Date:  2022-06-15       Impact factor: 1.878

6.  A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia.

Authors:  Maged M Costantine; Holly West; Katherine L Wisner; Steve Caritis; Shannon Clark; Raman Venkataramanan; Catherine S Stika; Erik Rytting; Xiaoming Wang; Mahmoud S Ahmed
Journal:  Am J Obstet Gynecol       Date:  2021-05-24       Impact factor: 8.661

7.  CLDN1 regulates trophoblast apoptosis and proliferation in preeclampsia.

Authors:  Yu-Chen Zhang; Xiao-Li Qin; Xiao-Ling Ma; Hui-Qin Mo; Shi Qin; Cheng-Xi Zhang; Xiao-Wei Wei; Xue-Qing Liu; Yan Zhang; Fu-Ju Tian; Yi Lin
Journal:  Reproduction       Date:  2021-05-05       Impact factor: 3.906

Review 8.  Maternal microvascular dysfunction during preeclamptic pregnancy.

Authors:  Anna E Stanhewicz; Virginia R Nuckols; Gary L Pierce
Journal:  Clin Sci (Lond)       Date:  2021-05-14       Impact factor: 6.876

Review 9.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

10.  Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study.

Authors:  Aris T Papageorghiou; Philippe Deruelle; Robert B Gunier; Stephen Rauch; Perla K García-May; Mohak Mhatre; Mustapha Ado Usman; Sherief Abd-Elsalam; Saturday Etuk; Lavone E Simmons; Raffaele Napolitano; Sonia Deantoni; Becky Liu; Federico Prefumo; Valeria Savasi; Marynéa Silva do Vale; Eric Baafi; Ghulam Zainab; Ricardo Nieto; Nerea Maiz; Muhammad Baffah Aminu; Jorge Arturo Cardona-Perez; Rachel Craik; Adele Winsey; Gabriela Tavchioska; Babagana Bako; Daniel Oros; Albertina Rego; Anne Caroline Benski; Fatimah Hassan-Hanga; Mónica Savorani; Francesca Giuliani; Loïc Sentilhes; Milagros Risso; Ken Takahashi; Carmen Vecchiarelli; Satoru Ikenoue; Ramachandran Thiruvengadam; Constanza P Soto Conti; Enrico Ferrazzi; Irene Cetin; Vincent Bizor Nachinab; Ernawati Ernawati; Eduardo A Duro; Alexey Kholin; Michelle L Firlit; Sarah Rae Easter; Joanna Sichitiu; Abimbola Bowale; Roberto Casale; Rosa Maria Cerbo; Paolo Ivo Cavoretto; Brenda Eskenazi; Jim G Thornton; Zulfiqar A Bhutta; Stephen H Kennedy; José Villar
Journal:  Am J Obstet Gynecol       Date:  2021-06-26       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.